Articles From: Chelsea Therapeutics to Present at BioCentury's 2013 Newsmakers in the Biotech Industry Conference to Chemed Corporation to Present at the Oppenheimer 24th Annual Healthcare Conference


2013/8/7
CHARLOTTE, N.C., Aug.
Sign-up for Chelsea Therapeutics to Present at the 2013 Wedbush Life Sciences Management Access Conference investment picks
MEDFORD, N.Y., Nov.
Sign-up for Chembio Board Member Named Winner of Commercialization Award by Purdue University investment picks
2013/9/5
MEDFORD, N.Y., Sept.
Sign-up for Chembio CEO Announces Retirement for May 2014 investment picks
2014/3/6
MEDFORD, N.Y., March 6, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) , a leader in point-of-care diagnostic tests for infectious diseases, today reported financial results for the quarter and year ended December 31, 2013, which include record revenues, and a tenth consecutive year of double-digit organic revenue growth.
Sign-up for Chembio Diagnostics Reports 2013 Financial Results investment picks
2013/8/8
NEW YORK, Aug.
Sign-up for Chembio Diagnostics Reports Second Quarter 2013 Financial Results investment picks
2013/11/7
MEDFORD, N.Y., Nov.
Sign-up for Chembio Diagnostics Reports Third Quarter 2013 Financial Results investment picks
2014/1/9
MEDFORD, N.Y., Jan.
Sign-up for Chembio Diagnostics to Present at Three Conferences in January 2014 investment picks
2014/2/12
MEDFORD, N.Y., Feb.
Sign-up for Chembio Enters Agreements With RVR in Southeast Asia investment picks
2013/12/2
MEDFORD, N.Y., Dec.
Sign-up for Chembio Files for CLIA Waiver with FDA for Point-of-Care DPP(R) HIV 1/2 Assay investment picks
Receives First Purchase Order from Mexican Distributor Multiplex HIV-Syphilis Assay Approved for USAID Waiver List, Now Eligible for U.S. Global Aid Procurements MEDFORD, N.Y., Oct.
Sign-up for Chembio Launches DPP(R) HIV-Syphilis Test investment picks
2014/3/28
MEDFORD, N.Y., March 28, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) , a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today named Katherine L.
Sign-up for Chembio Names Katherine L. Davis Chairman of the Board investment picks
2014/2/10
MEDFORD, N.Y., Feb.
Sign-up for Chembio Provides Update on DPP(R) HIV 1/2 Assay CLIA Waiver Application investment picks
2014/4/7
MEDFORD, N.Y., April 7, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care ("POC") diagnostic tests for infectious diseases, announced today that it notified Alere Inc., formerly Inverness Medical Innovations, Inc. ("Alere"), of termination of its U.S. STAT-PAK® distribution agreement.
Sign-up for Chembio Terminates U.S. Distribution Agreement With Alere investment picks
2014/2/20
MEDFORD, N.Y., Feb.
Sign-up for Chembio to Host Conference Call to Discuss 2013 Financial Results investment picks
MEDFORD, N.Y., July 25, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) , which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that the Company will release financial results for the second quarter of 2013, before the opening of the market on Thursday, August 8, 2013.
Sign-up for Chembio to Host Conference Call to Discuss Second Quarter 2013 Financial Results investment picks
MEDFORD, N.Y., Oct.
Sign-up for Chembio to Host Conference Call to Discuss Third Quarter 2013 Financial Results investment picks
MEDFORD, N.Y., Sept.
Sign-up for Chembio to Present at the Craig-Hallum Alpha Select Conference investment picks
MEDFORD, N.Y., Dec.
Sign-up for Chembio to Present at the LD Micro VI: The Main Event Conference investment picks
2014/3/25
MEDFORD, N.Y., March 25, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) , a leader in point-of-care ("POC") diagnostic tests for infectious diseases, announced today that its HIV 1/2 STAT-PAK® Assay received CE Mark approval from European regulators.
Sign-up for Chembio's HIV 1/2 STAT-PAK(R) Assay Receives CE Mark Approval for Rapid Point-of-Care Detection of HIV investment picks
2014/3/18
Chemed Corporation (NYSE: CHE) (“Chemed” or the “Company”) today announced the conversion rate on its 1.875% convertible senior notes due May 15, 2014, (the “notes”) has been adjusted to 12.7603 shares of Chemed's capital stock per $1,000 principal amount of the notes.
Sign-up for Chemed Corporation Announces Adjusted Conversion Rate On Its 1.875% Convertible Senior Notes Due May 15, 2014 investment picks
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 20 cents per share on the Company’s capital stock, payable on December 9, 2013, to shareholders of record as of November 18, 2013.
Sign-up for Chemed Corporation Declares Quarterly Dividend of 20 Cents investment picks
2014/2/21
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 20 cents per share on the Company’s capital stock, payable on March 24, 2014, to shareholders of record as of March 3, 2014.
Sign-up for Chemed Corporation Declares Quarterly Dividend of 20 Cents investment picks
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 20-cents per share on the Company’s capital stock, payable on September 3, 2013, to shareholders of record as of August 12, 2013.
Sign-up for Chemed Corporation Increases Quarterly Dividend 11.1% investment picks
2013/11/6
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 2013 Credit Suisse Healthcare Conference on Tuesday, November 12, 2013, at approximately 8:00 a.m. (MT) at the Phoenician Hotel in Scottsdale, AZ.
Sign-up for Chemed Corporation to Present at the 2013 Credit Suisse Healthcare Conference investment picks
2014/2/24
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets’ Healthcare Conference on Tuesday, February 25, 2014, at approximately 11:30 a.m. (ET) at The New York Palace Hotel in New York City.
Sign-up for Chemed Corporation to Present at the 2014 RBC Capital Markets’ Healthcare Conference investment picks
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 32nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2014, at approximately 2:00 p.m. PST at the Westin St.
Sign-up for Chemed Corporation to Present at the 32nd Annual J.P. Morgan Healthcare Conference investment picks
2014/3/5
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Barclays Capital 2014 Global Healthcare Conference on Wednesday, March 12, 2014, at approximately 2:30 p.m. (ET) at the Loews Miami Beach Hotel in Miami, Florida.
Sign-up for Chemed Corporation to Present at the Barclays Capital 2014 Global Healthcare Conference investment picks
2013/9/4
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Morgan Stanley Global Healthcare Conference on Wednesday, September 11, 2013, at approximately 10:00 a.m. (ET) at The Grand Hyatt Hotel in New York City.
Sign-up for Chemed Corporation to Present at the Morgan Stanley Global Healthcare Conference investment picks
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Oppenheimer 24th Annual Healthcare Conference on Tuesday, December 10, 2013, at approximately 1:00 p.m. (ET) at the Crowne Plaza Hotel in New York City.
Sign-up for Chemed Corporation to Present at the Oppenheimer 24th Annual Healthcare Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Chelsea Therapeutics to Present at BioCentury's 2013 Newsmakers in the Biotech Industry Conference to Chemed Corporation to Present at the Oppenheimer 24th Annual Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity